Invention Grant
US08013011B2 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof
有权
使用青蒿素及其衍生物治疗和预防良性色素痣（naevi）
- Patent Title: Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof
- Patent Title (中): 使用青蒿素及其衍生物治疗和预防良性色素痣（naevi）
-
Application No.: US12089773Application Date: 2006-10-19
-
Publication No.: US08013011B2Publication Date: 2011-09-06
- Inventor: Rosemarie Sift Carter
- Applicant: Rosemarie Sift Carter
- Applicant Address: CH Basel
- Assignee: EPIPHARM GmbH
- Current Assignee: EPIPHARM GmbH
- Current Assignee Address: CH Basel
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: CH1686/05 20051020; CH0514/06 20060330
- International Application: PCT/CH2006/000583 WO 20061019
- International Announcement: WO2007/045116 WO 20070426
- Main IPC: A61K31/357
- IPC: A61K31/357 ; A61K31/36 ; C07D493/22 ; A61P17/00
Abstract:
A method of treating a benign pigmented mole or a dermatomycosis. The method comprises locally applying to a subject in need thereof artemisinine and/or one or more structurally related compounds. Also disclosed is a plaster which comprises a topical formulation comprising artemisinine and/or one or more structurally related compounds.
Public/Granted literature
Information query
